Endonovo Therapeutics Stock Price Prediction
| ENDV Stock | USD 0.0004 0.0001 20.00% |
Oversold Vs Overbought
38
Oversold | Overbought |
Using Endonovo Therapeutics hype-based prediction, you can estimate the value of Endonovo Therapeutics from the perspective of Endonovo Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Endonovo Therapeutics to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Endonovo because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Endonovo Therapeutics after-hype prediction price | USD 4.61E-4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Endonovo |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Endonovo Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Endonovo Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Endonovo Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Endonovo Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Endonovo Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Endonovo Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Endonovo Therapeutics' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Endonovo Therapeutics' historical news coverage. Endonovo Therapeutics' after-hype downside and upside margins for the prediction period are 0.00 and 18.57, respectively. We have considered Endonovo Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Endonovo Therapeutics is out of control at this time. Analysis and calculation of next after-hype price of Endonovo Therapeutics is based on 3 months time horizon.
Endonovo Therapeutics Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Endonovo Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Endonovo Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Endonovo Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.34 | 18.41 | 0.00 | 0.03 | 0 Events / Month | 8 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.0004 | 0.0005 | 15.28 |
|
Endonovo Therapeutics Hype Timeline
Endonovo Therapeutics is currently traded for 0.0004. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.03. Endonovo is forecasted to increase in value after the next headline, with the price projected to jump to 4.61E-4 or above. The average volatility of media hype impact on the company the price is insignificant. The price increase on the next news is estimated to be 15.28%, whereas the daily expected return is currently at 0.34%. The volatility of related hype on Endonovo Therapeutics is about 18512.85%, with the expected price after the next announcement by competition of -0.03. Endonovo Therapeutics currently holds 7.36 M in liabilities. Debt can assist Endonovo Therapeutics until it has trouble settling it off, either with new capital or with free cash flow. So, Endonovo Therapeutics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Endonovo Therapeutics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Endonovo to invest in growth at high rates of return. When we think about Endonovo Therapeutics' use of debt, we should always consider it together with cash and equity.Given the investment horizon of 90 days the next forecasted press release will be in a few days. Check out Endonovo Therapeutics Basic Forecasting Models to cross-verify your projections.Endonovo Therapeutics Related Hype Analysis
Having access to credible news sources related to Endonovo Therapeutics' direct competition is more important than ever and may enhance your ability to predict Endonovo Therapeutics' future price movements. Getting to know how Endonovo Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Endonovo Therapeutics may potentially react to the hype associated with one of its peers.
Endonovo Therapeutics Additional Predictive Modules
Most predictive techniques to examine Endonovo price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Endonovo using various technical indicators. When you analyze Endonovo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Endonovo Therapeutics Predictive Indicators
The successful prediction of Endonovo Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Endonovo Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Endonovo Therapeutics based on analysis of Endonovo Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Endonovo Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Endonovo Therapeutics's related companies.
Story Coverage note for Endonovo Therapeutics
The number of cover stories for Endonovo Therapeutics depends on current market conditions and Endonovo Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Endonovo Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Endonovo Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Endonovo Therapeutics Short Properties
Endonovo Therapeutics' future price predictability will typically decrease when Endonovo Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Endonovo Therapeutics often depends not only on the future outlook of the potential Endonovo Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Endonovo Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 59.8 M | |
| Cash And Short Term Investments | 85.9 K |
Additional Tools for Endonovo Pink Sheet Analysis
When running Endonovo Therapeutics' price analysis, check to measure Endonovo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Endonovo Therapeutics is operating at the current time. Most of Endonovo Therapeutics' value examination focuses on studying past and present price action to predict the probability of Endonovo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Endonovo Therapeutics' price. Additionally, you may evaluate how the addition of Endonovo Therapeutics to your portfolios can decrease your overall portfolio volatility.